News

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...